Adimab: Adimab Announces Launch of Four New Proprietary Technologies
(marketscreener.com) - Heavy Chain-Only Antibody Libraries - - Heavy Chain/Light Chain and Heavy Chain/Heavy Chain Pairing Solutions for Multispecific Antibodies - - Fc Silencing Mutations to Attenuate Immune Signaling - - Antibody Half-life Extension Technology -https://www.marketscreener.com/news/latest/Adimab-Announces-Launch-of-Four-New-Proprietary-Technologies--37647092/?utm_medium=RSS&utm_content=20220126
Read full article »
Adimab is a New Hampshire-based biotechnology company that discovers monoclonal and bispecific antibodies for the healthcare industry.
Read more